tiprankstipranks
Advertisement
Advertisement

DRTS Stock Latest News

Alpha Tau price target raised to $8 from $5 at Piper Sandler
The FlyAlpha Tau price target raised to $8 from $5 at Piper Sandler
5d ago
DRTS
Alpha Tau Medical Sets June 23, 2026 Shareholder Meeting to Vote on Governance and Executive Pay
PremiumCompany Announcements
Alpha Tau Medical Sets June 23, 2026 Shareholder Meeting to Vote on Governance and Executive Pay
6d ago
6K
DRTS
Alpha Tau Medical Posts Strong Q1 2026 Trial Progress and Completes Enrollment in First U.S. Pivotal Study
PremiumCompany Announcements
Alpha Tau Medical Posts Strong Q1 2026 Trial Progress and Completes Enrollment in First U.S. Pivotal Study
6d ago
6K
DRTS
Alpha Tau reports Q1 EPS (12c), consensus (12c)
PremiumThe Fly
Alpha Tau reports Q1 EPS (12c), consensus (12c)
6d ago
DRTS
Alpha Tau Medical Ltd options imply 16.0% move in share price post-earnings
PremiumThe Fly
Alpha Tau Medical Ltd options imply 16.0% move in share price post-earnings
6d ago
DRTS
Alpha Tau price target raised to $14 from $12 at Ladenburg
PremiumThe FlyAlpha Tau price target raised to $14 from $12 at Ladenburg
12d ago
DRTS
Alpha Tau price target raised to $15 from $12 at H.C. Wainwright
Premium
The Fly
Alpha Tau price target raised to $15 from $12 at H.C. Wainwright
12d ago
DRTS
Alpha Tau Wiped Out Visible Tumors in Two of Three Brain Cancer Patients in Its First U.S. Trial
Premium
TipRanks Newswire
Alpha Tau Wiped Out Visible Tumors in Two of Three Brain Cancer Patients in Its First U.S. Trial
13d ago
DRTS
Alpha Tau Medical Shares Interim U.S. Glioblastoma Trial Data for Alpha DaRT
PremiumCompany Announcements
Alpha Tau Medical Shares Interim U.S. Glioblastoma Trial Data for Alpha DaRT
13d ago
6K
DRTS
Alpha Tau announces interim data from REGAIN trial
PremiumThe Fly
Alpha Tau announces interim data from REGAIN trial
13d ago
DRTS
Alpha Tau Posts Strong Interim REGAIN Data in U.S. Recurrent Glioblastoma Trial
PremiumCompany Announcements
Alpha Tau Posts Strong Interim REGAIN Data in U.S. Recurrent Glioblastoma Trial
13d ago
6K
DRTS
Alpha Tau completes enrollment in ReSTART trial
PremiumThe Fly
Alpha Tau completes enrollment in ReSTART trial
16d ago
DRTS
Alpha Tau Completes Enrollment in Pivotal U.S. Skin Cancer Trial for Alpha DaRT
PremiumCompany AnnouncementsAlpha Tau Completes Enrollment in Pivotal U.S. Skin Cancer Trial for Alpha DaRT
16d ago
6K
DRTS
Alpha Tau to Review Interim Data from First REGAIN Glioblastoma Patients
Premium
Company Announcements
Alpha Tau to Review Interim Data from First REGAIN Glioblastoma Patients
16d ago
6K
DRTS
Alpha Tau treats first patient with Alpha DaRT in Italy
Premium
The Fly
Alpha Tau treats first patient with Alpha DaRT in Italy
17d ago
DRTS
Alpha Tau Treats First Italian Pancreatic Cancer Patient With Alpha DaRT in Verona Study
PremiumCompany Announcements
Alpha Tau Treats First Italian Pancreatic Cancer Patient With Alpha DaRT in Verona Study
17d ago
6K
DRTS
Alpha Tau to Present Alpha DaRT–Pembrolizumab Head and Neck Cancer Data at AHNS 2026
PremiumCompany Announcements
Alpha Tau to Present Alpha DaRT–Pembrolizumab Head and Neck Cancer Data at AHNS 2026
19d ago
6K
DRTS
Alpha Tau presents updated results from two clinical trials of Alpha DaRT
PremiumThe Fly
Alpha Tau presents updated results from two clinical trials of Alpha DaRT
20d ago
DRTS
Alpha Tau Reports 100% Local Disease Control in Alpha DaRT Pancreatic Cancer Trials Presented at DDW 2026
PremiumCompany Announcements
Alpha Tau Reports 100% Local Disease Control in Alpha DaRT Pancreatic Cancer Trials Presented at DDW 2026
20d ago
6K
DRTS
Alpha Tau files $300M mixed securities shelf
PremiumThe FlyAlpha Tau files $300M mixed securities shelf
26d ago
DRTS
Alpha Tau to Present Pooled Pancreatic Cancer Alpha DaRT Data at 2026 ASCO Meeting
Premium
Company Announcements
Alpha Tau to Present Pooled Pancreatic Cancer Alpha DaRT Data at 2026 ASCO Meeting
27d ago
6K
DRTS
Alpha Tau gets FDA investigational device exemption supplement to IMPACT study
Premium
The Fly
Alpha Tau gets FDA investigational device exemption supplement to IMPACT study
1M ago
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >